{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:40:32Z","timestamp":1790005232722,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:00:00Z","timestamp":1600128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:00:00Z","timestamp":1600128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA046592"],"award-info":[{"award-number":["P30CA046592"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["T32CA083654"],"award-info":[{"award-number":["T32CA083654"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Cervical cancer is a leading cause of death in low- and middle-income countries. Self-collection testing for human papillomavirus (HPV) is an alternative form of cervical cancer screening that can be completed privately and at home. Understanding how the use of HPV testing influences follow-up care in low-resourced settings is crucial before broad implementation. This study aimed to identify if access to self-collection HPV testing impacts participation in established cervical cancer screening programs among women in two rural communities in Guatemala.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>A cohort of 956 women was recruited in 2016 and followed for 2 years for the HPV Multiethnic Study (HPV MES). At baseline, women answered a questionnaire assessing cervical cancer screening history and were offered self-collection HPV testing. Women were re-contacted yearly to determine receipt of additional screening. Statistical changes in screening behavior before and throughout study participation, stratified by self-collection status, were assessed using McNemar pair tests for proportions. Alluvial plots were constructed to depict changes in individual screening behavior. The odds of changes in Pap-compliance (screened in past 3 years), given collection status, were assessed using multivariate logistic regressions.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Reported screening rates increased 2 years after enrollment compared to rates reported for the 3 years before study entry among women who collected a sample (19.1% increase, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05), received results of their test (22.1% increase, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05), and received positive (24.2% increase, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.1) or negative results (21.7% increase, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). However, most increases came from one community, with minimal changes in the other. The adjusted odds of becoming Pap compliant were higher for women who collected a sample vs. did not (OR: 1.48, 95% CI: 0.64, 3.40), received their result vs. did not (OR: 1.29, 95% CI: 0.52, 3.02), and received a positive result vs. negative (OR: 2.43, 95% CI: 0.63, 16.10).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Participation in self-collection HPV testing campaigns may increase likelihood of involvement in screening programs. However, results varied between communities, and reporting of screening histories was inconsistent. Future work should identify what community-specific factors promote success in HPV testing programs and focus on\u00a0improving education on existing cervical cancer interventions.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12889-020-09478-8","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T13:03:46Z","timestamp":1600175026000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Using self-collection HPV testing to increase engagement in cervical cancer screening programs in rural Guatemala: a longitudinal analysis"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3095-2323","authenticated-orcid":false,"given":"Anna","family":"Gottschlich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Rivera-Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Bevilacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey R.","family":"Murchland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ergest","family":"Isak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian S.","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Ogilvie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Carey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Prince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Mendoza-Montano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Meza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,15]]},"reference":[{"key":"9478_CR1","unstructured":"World Health Organization. Human papillomavirus (HPV) and cervical cancer: Geneva. WHO Fact Sheets; 2019. p. 1\u20137."},{"issue":"SUPPL 2","key":"9478_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ijgo.2005.01.009","volume":"89","author":"R Sankaranarayanan","year":"2005","unstructured":"Sankaranarayanan R, Gaffikin L, Jacob M, Sellors J, Robles S. A critical assessment of screening methods for cervical neoplasia. Int J Gynecol Obstet. 2005;89(SUPPL 2):4\u201312.","journal-title":"Int J Gynecol Obstet"},{"key":"9478_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.5306\/wjco.v6.i6.281","volume":"6","author":"R Catarino","year":"2015","unstructured":"Catarino R. Cervical cancer screening in developing countries at a crossroad: emerging technologies and policy choices. World J Clin Oncol. 2015;6:281.","journal-title":"World J Clin Oncol"},{"key":"9478_CR4","volume-title":"National Census of Population","author":"Instituto Nacional de Estadistica Guatemala","year":"2018","unstructured":"Instituto Nacional de Estadistica Guatemala. National Census of Population. 2018."},{"key":"9478_CR5","unstructured":"Central Intelligence Agency. Central America, Guatemala: CIA World Factbook; 2019."},{"key":"9478_CR6","volume-title":"Encuesta Nacional de Salud Materno Infantil 2014-2015: Informe Final","author":"MSPAS M de SP y AS, INE IN de E, Segeplan S de P y P de la P, DHS D and HS","year":"2017","unstructured":"MSPAS M de SP y AS, INE IN de E, Segeplan S de P y P de la P, DHS D and HS. Encuesta Nacional de Salud Materno Infantil 2014-2015: Informe Final 2017."},{"key":"9478_CR7","unstructured":"Globocan: Cancer Today. Estimated number of new cases in 2018, cervix uteri, females, all ages: International Agency for Research on Cancer, World Health Organization; 2019."},{"key":"9478_CR8","volume-title":"Plan nacional de prevenci\u00f3n, control y manejo de c\u00e1ncer cervicouterino 2014\u20132024","author":"Ministerio de Salud P\u00fablica y Asistencia Social","year":"2014","unstructured":"Ministerio de Salud P\u00fablica y Asistencia Social. Plan nacional de prevenci\u00f3n, control y manejo de c\u00e1ncer cervicouterino 2014\u20132024. 2014."},{"issue":"14","key":"9478_CR9","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jama.288.14.1749","volume":"288","author":"SL Kulasingam","year":"2002","unstructured":"Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, et al. Evaluation of Human Papillomavirus Testing in Primary Screening for Cervical Abnormalities Comparison of Sensitivity, Specificity, and Frequency of Referral. JAMA. 2002;288(14):1749\u201357.","journal-title":"JAMA"},{"key":"9478_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/msj.20263","volume":"78","author":"L Ditzian","year":"2011","unstructured":"Ditzian L, David-West G, Maza M, Hartmann B, Shirazian T, Cremer M. Cervical Cancer screening in low- and middle-income countries. Mt Sinai J Med. 2011;78:319\u201326.","journal-title":"Mt Sinai J Med"},{"key":"9478_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0170631","volume":"12","author":"AO Raifu","year":"2017","unstructured":"Raifu AO, El-Zein M, Sangwa-Lugoma G, Ramanakumar A, Walter SD, Franco EL, et al. Determinants of cervical cancer screening accuracy for visual inspection with acetic acid (VIA) and lugol\u2019s iodine (VILI) performed by nurse and physician. PLoS One. 2017;12:1\u201313.","journal-title":"PLoS One"},{"key":"9478_CR12","first-page":"635","volume":"99","author":"JW Sellors","year":"2002","unstructured":"Sellors JW, Jeronimo J, Sankaranarayanan R, Wright TC, Howard M, Blumenthal PD. Assessment of the cervix after acetic acid wash: inter-rater agreement using photographs. Obstet Gynecol. 2002;99:635\u201340.","journal-title":"Obstet Gynecol"},{"key":"9478_CR13","doi-asserted-by":"crossref","unstructured":"Gottschlich A, Ochoa P, Rivera-Andrade A, Alvarez CS, Montano CM, Camel C, et al. Barriers to Cervical Cancer Screening in Guatemala: A Quantitative Analysis Using Data from the Guatemala Demographic and Health Surveys. Int J Public Health. 2019; In press.","DOI":"10.1007\/s00038-019-01319-9"},{"issue":"March","key":"9478_CR14","doi-asserted-by":"publisher","first-page":"e670","DOI":"10.1136\/bmj.e670","volume":"344","author":"IMCM de Kok","year":"2012","unstructured":"de Kok IMCM, van Rosmalen J, Dillner J, Arbyn M, Sasieni P, Iftner T, et al. Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model. BMJ. 2012;344(March):e670.","journal-title":"BMJ"},{"key":"9478_CR15","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1128\/JCM.02570-10","volume":"49","author":"M Benevolo","year":"2011","unstructured":"Benevolo M, Vocaturo A, Caraceni D, French D, Rosini S, Zappacosta R, et al. Sensitivity, specificity, and clinical value of human papillomavirus (HPV) E6\/E7 mRNA assay as a triage test for cervical cytology and HPV DNA test. J Clin Microbiol. 2011;49:2643\u201350.","journal-title":"J Clin Microbiol"},{"key":"9478_CR16","doi-asserted-by":"publisher","first-page":"dju153","DOI":"10.1093\/jnci\/dju153","volume":"106","author":"JC Gage","year":"2014","unstructured":"Gage JC, Schiffman M, Katki HA, Castle PE, Fetterman B, Wentzensen N, et al. Reassurance Against Future Risk of Precancer and Cancer Conferred by a Negative Human Papillomavirus Test. JNCI J Natl Cancer Inst. 2014;106:dju153.","journal-title":"JNCI J Natl Cancer Inst"},{"key":"9478_CR17","doi-asserted-by":"publisher","first-page":"i4924","DOI":"10.1136\/bmj.i4924","volume":"355","author":"MG Dijkstra","year":"2016","unstructured":"Dijkstra MG, van Zummeren M, Rozendaal L, van Kemenade FJ, Helmerhorst TJM, Snijders PJF, et al. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands. BMJ. 2016;355:i4924.","journal-title":"BMJ"},{"key":"9478_CR18","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0140-6736(20)30068-4","volume":"395","author":"M Brisson","year":"2020","unstructured":"Brisson M, Kim JJ, Canfell K, Drolet M, Gingras G, Burger EA, et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020;395:575\u201390.","journal-title":"Lancet"},{"key":"9478_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2019-029158","volume":"9","author":"AR Murchland","year":"2019","unstructured":"Murchland AR, Gottschlich A, Bevilacqua K, Pineda A, Sandoval-Ram\u00edrez BA, Alvarez CS, et al. HPV self-sampling acceptability in rural and indigenous communities in Guatemala: a cross-sectional study. BMJ Open. 2019;9:1\u201312.","journal-title":"BMJ Open"},{"key":"9478_CR20","doi-asserted-by":"crossref","unstructured":"Gottschlich A, Rivera-Andrade A, Grajeda E, Alvarez C, Montano CM, Meza R. Acceptability of Human Papillomavirus Self-Sampling for Cervical Cancer Screening in an Indigenous Community in Guatemala. J Glob Oncol. 2017;3:5,444\u2013454.","DOI":"10.1200\/JGO.2016.005629"},{"key":"9478_CR21","unstructured":"Jeronimo J. Scale-up project for cervical cancer prevention establishing routine use of HPV testing to prevent cervical cancer in low-resource settings. Path. 2015. p. 1\u20132. https:\/\/path.azureedge.net\/media\/documents\/RH_scale_up_cervical_cancer_prev_pb.pdf."},{"key":"9478_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13012-017-0548-1","volume":"12","author":"S Arrossi","year":"2017","unstructured":"Arrossi S, Paolino M, Thouyaret L, Laudi R, Campanera A. Evaluation of scaling-up of HPV self-collection offered by community health workers at home visits to increase screening among socially vulnerable under-screened women in Jujuy Province, Argentina. Implement Sci. 2017;12:1\u201311.","journal-title":"Implement Sci"},{"issue":"SUPPL 11","key":"9478_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.vaccine.2008.05.026","volume":"26","author":"EL Franco","year":"2008","unstructured":"Franco EL, Tsu V, Herrero R, Lazcano-Ponce E, Hildesheim A, Mu\u00f1oz N, et al. Integration of human papillomavirus vaccination and cervical Cancer screening in Latin America and the Caribbean. Vaccine. 2008;26(SUPPL 11):88\u201395.","journal-title":"Vaccine"},{"key":"9478_CR24","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1016\/j.canep.2016.07.015","volume":"44","author":"R Murillo","year":"2016","unstructured":"Murillo R, Herrero R, Sierra MS, Forman D. Cervical cancer in central and South America: burden of disease and status of disease control. Cancer Epidemiol. 2016;44:S121\u201330.","journal-title":"Cancer Epidemiol"},{"key":"9478_CR25","doi-asserted-by":"publisher","first-page":"307","DOI":"10.9745\/GHSP-D-14-00073","volume":"2","author":"AN Chary","year":"2014","unstructured":"Chary AN, Rohloff PJ. Major challenges to scale up of visual inspection-based cervical cancer prevention programs: the experience of Guatemalan NGOs. Glob Health Sci Pract. 2014;2:307\u201317.","journal-title":"Glob Health Sci Pract"},{"key":"9478_CR26","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.ejca.2015.07.006","volume":"51","author":"F Verdoodt","year":"2015","unstructured":"Verdoodt F, Jentschke M, Hillemanns P, Racey CS, Snijders PJF, Arbyn M. Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials. Eur J Cancer. 2015;51:2375\u201385.","journal-title":"Eur J Cancer"},{"key":"9478_CR27","doi-asserted-by":"crossref","unstructured":"Bonita R, Winkelmann R, Douglas KA, de Courten M. The WHO Stepwise Approach to Surveillance (Steps) of Non-Communicable Disease Risk Factors. Glob Behav Risk Factor Surveill. 2003:9\u201322. https:\/\/www.who.int\/ncd_surveillance\/en\/steps_framework_dec03.pdf.","DOI":"10.1007\/978-1-4615-0071-1_3"},{"key":"9478_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2018-021618","volume":"8","author":"MC Eisenberg","year":"2018","unstructured":"Eisenberg MC, Campredon LP, Brouwer AF, Walline HM, Marinelli BM, Lau YK, et al. Dynamics and determinants of HPV infection: the Michigan HPV and Oropharyngeal Cancer (M-HOC) study. BMJ Open. 2018;8:1\u20137.","journal-title":"BMJ Open"},{"key":"9478_CR29","volume-title":"Improving Data for Decision-Making: A Tool Kit for Cervical Cancer Prevention and Control Programs","author":"World Health Organization, Centers for Disease Control and Prevention, CDC Foundation, George W. Bush Institute","year":"2018","unstructured":"World Health Organization, Centers for Disease Control and Prevention, CDC Foundation, George W. Bush Institute. Improving Data for Decision-Making: A Tool Kit for Cervical Cancer Prevention and Control Programs. 2018."},{"key":"9478_CR30","volume-title":"Guias Nacionales para el tamizaje y tratamiento de las lesiones precancerosas para la prevenci\u00f3n del c\u00e1ncer de cervicouterino","author":"LEM de Le\u00f3n","year":"2014","unstructured":"de Le\u00f3n LEM, Vila FFB, Boj\u00f3rquez IL, Pinto WES, Batz EMV, Chac\u00f3n CLV, et al. Guias Nacionales para el tamizaje y tratamiento de las lesiones precancerosas para la prevenci\u00f3n del c\u00e1ncer de cervicouterino. 2014."},{"key":"9478_CR31","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1186\/1471-2458-14-596","volume":"14","author":"P Bansil","year":"2014","unstructured":"Bansil P, Wittet S, Lim JL, Winkler JL, Paul P, Jeronimo J. Acceptability of self-collection sampling for HPV-DNA testing in low-resource settings: a mixed methods approach. BMC Public Health. 2014;14:596.","journal-title":"BMC Public Health"},{"key":"9478_CR32","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ijgo.2014.09.016","volume":"128","author":"M Mandigo","year":"2015","unstructured":"Mandigo M, Frett B, Laurent JR, Bishop I, Raymondville M, Marsh S, et al. Pairing community health workers with HPV self-sampling for cervical cancer prevention in rural Haiti. Int J Gynecol Obstet. 2015;128:206\u201310.","journal-title":"Int J Gynecol Obstet"},{"key":"9478_CR33","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/sextrans-2016-052609","volume":"93","author":"EJ Nelson","year":"2017","unstructured":"Nelson EJ, Maynard BR, Loux T, Fatla J, Gordon R, Arnold LD. The acceptability of self-sampled screening for HPV DNA: a systematic review and meta-analysis. Sex Transm Infect. 2017;93:56\u201361.","journal-title":"Sex Transm Infect"},{"key":"9478_CR34","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1111\/tmi.12549","volume":"20","author":"E Moses","year":"2015","unstructured":"Moses E, Pedersen HN, Mitchell SM, Sekikubo M, Mwesigwa D, Singer J, et al. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial. Trop Med Int Health. 2015;20:1355\u201367.","journal-title":"Trop Med Int Health"},{"key":"9478_CR35","first-page":"97","volume":"26","author":"JA Bowman","year":"1991","unstructured":"Bowman JA, Redman S, Dickinson JA, Gibberd R, Sanson-Fisher RW. The accuracy of pap smear utilization self-report: a methodological consideration in cervical screening research. Health Serv Res. 1991;26:97\u2013107.","journal-title":"Health Serv Res"},{"key":"9478_CR36","first-page":"721","volume":"5","author":"ED Paskett","year":"1996","unstructured":"Paskett ED, Tatum CM, Mack DW, Hoen H, Case LD, Velez R. Validation of self-reported breast and cervical cancer screening tests among low-income minority women. Cancer Epidemiol Biomark Prev. 1996;5:721\u20136.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"9478_CR37","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1001\/archpedi.158.10.966","volume":"158","author":"DR Blake","year":"2004","unstructured":"Blake DR, Weber BM, Fletcher KE. Adolescent and young adult women\u2019s misunderstanding of the term pap smear. Arch Pediatr Adolesc Med. 2004;158:966\u201370.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"9478_CR38","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1001\/jama.2018.10400","volume":"320","author":"J Melnikow","year":"2018","unstructured":"Melnikow J, Henderson JT, Burda BU, Senger CA, Durbin S, Weyrich MS. Screening for cervical cancer with high-risk human papillomavirus testing updated evidence report and systematic review for the us preventive services task force. JAMA. 2018;320:687\u2013705.","journal-title":"JAMA"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-020-09478-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-020-09478-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-020-09478-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T23:14:33Z","timestamp":1631661273000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-020-09478-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,15]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["9478"],"URL":"https:\/\/doi.org\/10.1186\/s12889-020-09478-8","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,15]]},"assertion":[{"value":"10 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The University of Michigan Institutional Review Board (HUM00096559) and the Institute of Nutrition of Central America and Panama Institutional Review Board (MI-CIE-16-009) approved study protocols. All participants gave oral and written informed consent prior to participation in the study. The consent was documented by a signature or fingerprint of the participant, the surveyors, and a witness.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1406"}}